Clinical trial Recruiting at 1 site Observational Ages 18 to 50 Women only

Do prenatal effects on baby development occur in IVF pregnancies without shared genes?

Official title: Leveraging IVF to Identify Prenatal Effects Independent of Shared Maternal-Child Genes

Run by Columbia University · NCT07296107 · Data updated 2026-11-12

This research will test whether maternal stress during pregnancy affects a baby's brain and behavior even when the mother and baby do not share genes by comparing donor-egg/embryo IVF pregnancies with non-donor IVF pregnancies.

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexWomen only
Enrollment360 (estimated)
SponsorColumbia University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 8, 2026
Main results expectedJuly 31, 2030
Study endsJuly 31, 2030
Registry record updatedJuly 7, 2026
Trial IDNCT07296107 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant individuals aged 18–50 at 18–28 weeks gestation with IVF pregnancies (either donor oocyte/embryo or non-donor) who receive prenatal care and plan to deliver at Columbia University Irving Medical Center/NewYork-Presbyterian Morgan Stanley Children's Hospital are ideal candidates.

Probably not a fit

People with an active addiction disorder, severe unmanaged psychiatric conditions, or those who do not receive care or deliver at the specified Columbia/NewYork-Presbyterian sites are not expected to benefit or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project compares pregnancies conceived with donor eggs or embryos (no shared maternal-child genetics) to non-donor IVF pregnancies to separate prenatal environmental effects from shared genes. Pregnant participants complete questionnaires and provide blood samples, while fetal monitoring captures fetal heart rate patterns in the third trimester. After birth, the team collects placenta and cord blood and performs newborn brain activity assessments to link prenatal stress and biological markers to early neurobehavioral outcomes. Epigenetic and transcriptomic analyses of the placenta will test whether maternal distress relates to gene methylation patterns that could mediate infant outcomes.

Why it matters

Potential benefit: If successful, this work could clarify whether prenatal mental health directly influences infant brain development and help target prenatal mental health support to improve child outcomes.

How similar studies have gone: Decades of DOHaD research link prenatal maternal distress to child outcomes, but using donor-conception IVF to separate genetic from prenatal effects in a multidisciplinary epigenetic and neurobehavioral design is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Individuals at 18-28 gestational weeks with donor and homologous IVF pregnancies, ages 18-50.
2. Participants must be patients receiving their perinatal health care through Columbia University Irving Medical Center's Department of OB/GYN and delivering at New York-Presbyterian Morgan Stanley Children's Hospital.
3. Participants must be patients delivering at Columbia University Irving Medical Center's Department of OB/GYN and delivering at New York-Presbyterian Morgan Stanley Children's Hospital.
4. Participants will include the offspring of patients receiving care and delivering at the above institutions.
5. Enrollment Location(s): Columbia University Irving Medical Center's Department of OB/GYN, delivering at New York-Presbyterian Morgan Stanley Children's Hospital.

Exclusion Criteria:

1. Identified addiction disorder
2. Severe psychiatric condition (defined as symptoms that significantly impair daily functioning and are untreated or not effectively managed)
3. Multiple fetal pregnancy
4. Known chromosomal, genetic, or major fetal malformations (unlikely due to routine preimplantation genetic testing)
5. Inflammatory conditions including rheumatoid arthritis, lupus, and multiple sclerosis
6. Not planning to deliver at a CUIMC-affiliated hospital

Where it's running

  • Columbia University Irving Medical Center/New York Presbyterian Hospital
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.